Agenda Highlights Unveiled: 2023 Changping Healthcare & Finance Innovation Forum and 2023 Future Healthcare Equity Investment Forum to Convene!
The life sciences sector is flourishing, making the pharmaceutical and healthcare industry one of the most dynamic arenas for global innovation. After nearly three years of innovative oscillation, the industry entered a new cycle in 2023. From a macro perspective, R&D and investment in the pharmaceutical and healthcare sector are becoming more rational, whether driven by clinical value or focused on differentiated innovation. In the face of external changes, innovation remains the key to success for pharmaceutical and healthcare companies striving to compete, as well as for the high-quality development of the entire industry. Meanwhile, sci-tech finance has become the optimal engine driving corporate growth.
Changping is a key hub for Beijing’s construction of an international science and technology innovation center, as well as a vital base for establishing an innovation engine in the pharmaceutical and health industries. Over the past two years, Changping has prioritized the pharmaceutical and health sectors as its leading advantageous industries, introducing a series of policy measures such as the Industry Doubling Action Plan to accelerate the development of a trillion-yuan industrial cluster.In terms of industrial investment, Changping District leverages Chang Development Company as its primary platform, securing fund cooperation exceeding RMB 29 billion. By partnering with 24 high-quality healthcare funds, including Huagai Capital and Sinovation Ventures’ Songhe Capital, the district has provided robust support for the rapid development of the pharmaceutical and health industry.
To accelerate the development of “Life Valley” to a globally leading level, create a “tipping point” for Beijing’s pharmaceutical and health industry, and jointly promote its high-quality development, Changping District is committed to building an ever-lasting international forum on life sciences. As2023One of the Thematic Forums of the Changping International Life Science Forum——2023ChangpingForum on Innovation in Financial Investment for Medicine and Healthto be held onNovember 17, 2023InTaikang Research Institute · Changping, BeijingHosted.
Meanwhile,VCBeatVB100 is preparing for the 2023 Future Healthcare Equity Investment Forum and the 5th Future Healthcare Fund Partners (LP-GP) Summit, which will be held at the same venue on November 18.
Event 1: 2023 Future Healthcare Equity Investment Forum
Forum Name:2023 Future Healthcare Equity Investment Forum
Forum Schedule:November 18, 2023
Forum Venue:Beijing Changping · Taikang Training Institute
Organizational Structure:
Organizers: VB100, VCBeat, Eggshell Institute
Co-organized by: Changfazhan
Forum Scale:300 people
· Forum Registration ·
Scan the QR Code to Register for Free
(Limited free giveaway(Tickets, while supplies last)
Ticket Benefits:
1. One ticket to the 2023 Future Healthcare Equity Investment Forum
2. On-site Forum Liaison Group
3. Guest Authorization for Post-Event Video Playback
Forum Agenda Planning
*LatestThe agenda is subject to change based on the actual schedule at the forum venue.
Roadshow Project Details：First Look | 2023 Future Healthcare Equity Investment Forum: First Release of Roadshow Project List! - VCBeat (vbdata.cn)
Event 2: 2023 Changping Pharmaceutical and Health Finance Investment Innovation Forum
Forum Date: November 17, 2023
Venue: Lecture Hall, 1st Floor, Taikang Academy, Changping, Beijing
Forum Scale: 300-400 Attendees
Forum Organizing Committee:
Organizer:
People's Government of Changping District, Beijing Municipality
Organizer:
Administrative Committee of Future Science City (Life Park Administrative Committee)
Administrative Committee of Changping Park, Zhongguancun Science Park
Beijing Changping District Financial Services Office
Beijing Changping Science Park Technology Development Co., Ltd.
Beijing Zhongguancun Life Science Park Development Co., Ltd.
Beijing Danhuang Technology Co., Ltd. (VCBeat VB100)
· Forum Registration ·
Scan the QR Code to Register for Free
Ticket Benefits:
(Including the report released at this forum (electronic version))
On-Site Resource Coordination Group
Selected Keynote Speeches and Roundtable Discussion Transcripts from the Forum
Forum Lunch Ticket
Centered on the core theme of pharmaceutical and healthcare industry development and financial empowerment, the forum will feature in-depth discussions on innovative development in the sector, investment and empowerment by fund-of-funds, fundraising, investment, management, and exit strategies for subsidiary funds, as well as investment strategies and trends in hot life science sectors, delivering high-quality content sharing.
▸ Host's Opening Remarks
▸ Forum Address
▸ Synthetic Biology and Biomanufacturing
10:20-10:40
Leader in Charge, Beijing Stock Exchange
▸ Leveraging the Advantages of Insurance Capital to Support Innovative Development in the Medical, Elderly Care, and Health Industries
11:00-11:40
Liu Guoen | Dean of the Institute for Global Health Development, Peking University; Member of the Academic Division, Chinese Academy of Medical Sciences
Xie Xin | Executive Director and Senior Vice President, China Biopharmaceutical
▸ Signing Ceremony for the Cooperative Fund
▸ 2023 Global Healthcare Industry Capital Report
Bi Yuanfeng | Co-founder and COO of VCBeat
12:00-14:00
▸ Lunch Break
14:00-15:00
▸ Strategies for Chinese Innovative Pharmaceutical Companies to Balance Breakthroughs and Stability for Long-Term Development Amid Strengthened Source Innovation and Commercialization of Achievements
Roundtable Moderator:Gao Jieliang | CDH Innovation & Growth FundSenior Partner
Roundtable Panelists:
Li Qichen | Co-founder and General Manager of ImmuneOnco
Shang Yuanfang | Founder and CEO of CytoNexus Biosciences
Tian Wenzhi | Chairman, CEO and CSO of ImmuneOnco
Xu Qian | General Manager, Beijing Office and Managing Partner, Danlu Capital
Yang Bin | Director, Center for Smart Health, Institute for Precision Medicine, Tsinghua University
Zhang Yi | Managing Partner, Early-Stage Fund, Huagai Medical
15:00-16:00
▸ How Chinese Medical Device Companies Can Break the Ice Amid Great-Power Rivalry
Roundtable Moderator: Tang Haofu | Partner, Chongqing Dianshi Chuangjian Fund / Shanghai Chuangrui Fund
Roundtable Guests:
Bai Yuan | Co-founder and Deputy General Manager of Huapu Instruments
Jie Jing | CTO of Weimai Medical
Zhang Jiang | Founder and CEO of LRI Jiangyuan Investment
Zhang Yiling | Chairman of Changmugu
Zhu Zhicheng | Deputy General Manager, Jiuyiyuan
Zhou Yixin | Director of the Department of Orthopedic Surgery, Beijing Jishuitan Hospital; Professor at Peking University Health Science Center
16:00-17:00
▸ Pathways for Service and Operation Agencies to Enhance Capabilities under the Requirements for High-Quality Development of Industrial Parks
Roundtable Moderator: Li Yang | Head of Yuanyi Digital Health Accelerator
Roundtable Panelists:
Kang Haihua | Senior Managing Director at Qiao Capital and CEO of the Qiao Healthcare Industry Infrastructure Platform
Wang Hui | Founder of Hongrun Health Group
Zang Dongning | Vice President, Clinical Development, Thermo Fisher Scientific China
Zhao Weiwen | General Manager, BGI Blue Rainbow Life Sciences Accelerator
Zheng Xiaoyu | Executive President of Beijing Gaobo Hospital and Beijing Gaobo Boren Hospital
Zhuang Jia | Head of ATLATL Innovation Department, Executive Director of ATLATL Venture Capital
17:00-18:00
▸ Survival Paths for Capital and the Pharmaceutical Industry in a Complex Macroeconomic Environment
Roundtable Moderator: Tao Yu | Executive General Manager of Changkejin Company
Roundtable Panelists:
Li Fan | Fosun Global Partner, CEO of FOSUN Capital
Li Jiangfeng | Partner, Fortune Capital
Liu Yu | General Manager and Managing Partner, BGI Win-Win
Shi Huijing | Founding Partner of Yahui Investment
Zhao Gang | Partner, SoftBank China Capital
Note: The agenda is for reference only. Please refer to the on-site schedule for the final topics and speakers.
·Forum Collaboration·
This forum embraces open ecosystem collaboration and sincerely invites partners from the pharmaceutical, healthcare, and financial investment sectors to provide relevant support.
Forum sponsorship opportunities include: meal voucher advertising, bottled water advertising, inclusion of promotional materials in attendee bags, basic booth spaces, and gift sponsorships.
For details on forum collaboration, please inquire:【Chang Development】Ms. Ma - 15911122053 (WeChat ID same as phone number)
· Contact Us ·
Conference Inquiry: [VB100] Ms. Peng - 13364027163 (WeChat ID same)
Media Partnership: [VB100] Ms. Zou - 15213067481 (WeChat ID same as phone number)